HUMAN AND MURINE MODELS OF TYPE V COLLAGEN DEFICIENCY
HUMAN AND MURINE MODELS OF TYPE V COLLAGEN DEFICIENCY
批准号:
6167100
负责人:
RICHARD J. WENSTRUP
金额:
$21.74万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-21 至 2004-07-31
关键词:
Ehlers Danlos syndrome cell cell interaction clinical research collagen cornea family genetics fibrogenesis genetic disorder diagnosis genetically modified animals human genetic material tag human tissue molecular chaperones polymerization protein isoforms protein structure function skin tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) - Type V collagen is a
member of the subclass of fibrillar collagens that is present in minor amounts
in virtually all non-cartilaginous connective tissues. As demonstrated by the
applicant and others haploinsufficiency of pro-alpha1 (V) collagen chains
frequently causes the classical form of Ehlers-Danlos syndrome (EDS I/II) which
is characterized by joint laxity and dislocations, severe dermal fragility, and
defective wound healing. Therefore, the biomechanical integrity of some
connective tissues including skin, tendon, and ligaments appears to be
exquisitely sensitive to the quantity of pro-alpha1 (V) chains available to
participate in fibrillogenesis, yet other pro-alpha1(V)-containing tissues
appear relatively unaffected. Experiments proposed by the applicant are
designed to elucidate the role of type V collagen in regulating mechanical
properties of tissues. In the first aim the products of pro-alpha1(V)
expression genes containing C-propeptide mutations will be analyzed for their
ability to self trimerize or to form trimers with wild-type pro-alpha1 (V)
chains and pro-alpha2(V) chains. Binding of normal and mutant c-propeptides to
chaperone proteins will be analyzed by chemical cross-linking and
immunoprecipitation. Fibril shape and deposition of collagens and
noncollagenous collagen-binding molecules will be measured in long-term dermal
fibroblast cultures. In the second aim the molecular determinants of type V/XI
chain selection will be analyzed by trimerization experiments in which full
length or minigenes expressing the C-propeptides for pro-alpha1 (V), pro-alpha2
(V), and pro-alpha1 (XI) as well as a novel C-propeptide splice variant of
pro-alpha1 (V) will be assembled in vitro and in cellulo after transfection in
several cell types having restricted expression of type V/XI collagen chains.
In the third aim homozygous and heterozygous col5A1 knockout mice will be
analyzed for changes in type-specific collagen deposition in tissues and
long-term fibroblast cultures from skin, which is severely affected in human
col5A1 haploinsufficiency, and also in cornea, which appears to be spared even
though type V collagen's role in collagen fibrillogenesis in cornea is well
documented. In the fourth aim fibril morphology, biochemistry, and
biomechanical characteristics of cornea and dermis in col5A1-deficient mice
will be examined to determine the relationship between total type V collagen
content, type V/type XI isoform ratios, noncollagenous protein content, and
biomechanical properties.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALENDRONATE DISODIUM IN PEDIATRIC GAUCHER DISEASE
-
批准号:7607734
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2007
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
OSTEOGENESIS IMPERFECTA/IV ZOLEDRONIC ACID VS IV PAMIDRONATE
-
批准号:7607748
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2007
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
OSTEOGENESIS IMPERFECTA/IV ZOLEDRONIC ACID VS IV PAMIDRONATE
-
批准号:7374524
-
项目类别:
-
资助金额:$3.37万
-
财政年份:2005
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
ALENDRONATE DISODIUM IN PEDIATRIC GAUCHER DISEASE
-
批准号:7374505
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2005
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
OSTEOGENESIS IMPERFECTA/IV ZOLEDRONIC ACID VS IV PAMIDRONATE
-
批准号:7203779
-
项目类别:
-
资助金额:$4.56万
-
财政年份:2004
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
ALENDRONATE DISODIUM IN PEDIATRIC GAUCHER DISEASE
-
批准号:7203753
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2004
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
Use of Hammerhead Ribozymes in Murine Models of Ol
-
批准号:6728243
-
项目类别:
-
资助金额:$39.82万
-
财政年份:2003
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
Use of Hammerhead Ribozymes in Murine Models of Ol
-
批准号:6879177
-
项目类别:
-
资助金额:$40.98万
-
财政年份:2003
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
Alendronate Disodium in Pediatric Gaucher Disease
-
批准号:7044192
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2003
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
Use of Hammerhead Ribozymes in Murine Models of Ol
-
批准号:6628093
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2003
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
HUMAN AND MURINE MODELS OF TYPE V COLLAGEN DEFICIENCY
-
批准号:6533000
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2000
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
ANTIRESORPTIVE THERAPY FOR OSTEOPENIA IN GAUCHER DISEASE
-
批准号:6414959
-
项目类别:
-
资助金额:$2.85万
-
财政年份:2000
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
HUMAN AND MURINE MODELS OF TYPE V COLLAGEN DEFICIENCY
-
批准号:6375335
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2000
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
HUMAN AND MURINE MODELS OF TYPE V COLLAGEN DEFICIENCY
-
批准号:6662714
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2000
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
ANTIRESORPTIVE THERAPY FOR OSTEOPENIA IN GAUCHER DISEASE
-
批准号:6309938
-
项目类别:
-
资助金额:$2.85万
-
财政年份:1999
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
ANTIRESORPTIVE THERAPY FOR OSTEOPENIA IN GAUCHER DISEASE
-
批准号:6295053
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1998
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
ANTIRESORPTIVE THERAPY FOR OSTEOPENIA IN GAUCHER DISEASE
-
批准号:6122874
-
项目类别:
-
资助金额:$0.39万
-
财政年份:1998
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
ANTIRESORPTIVE THERAPY FOR OSTEOPENIA IN GAUCHER DISEASE
-
批准号:6282880
-
项目类别:
-
资助金额:$2.34万
-
财政年份:1997
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
GENETIC PREDISPOSITION TO ADULT OSTEOPENIA
-
批准号:3509527
-
项目类别:
-
资助金额:$5.73万
-
财政年份:1992
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
GENETIC PREDISPOSITION TO OSTEOPENIA IN OLDER ADULTS
-
批准号:3509528
-
项目类别:
-
资助金额:$4.27万
-
财政年份:1992
-
负责人:RICHARD J. WENSTRUP
-
依托单位:
海外基金